Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
NCT03030066
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioma
Interventions
DRUG:
DS-1001b
Sponsor
Daiichi Sankyo